• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Predictors of Mortality in 217 COVID-19 Patients in Northwest Ohio, United States: A Retrospective Study

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Dec 22.
doi: 10.1002/jmv.26750. Online ahead of print.
Predictors of Mortality in 217 COVID-19 Patients in Northwest Ohio, United States: A Retrospective Study


Ganesh Prasad Merugu[SUP] 1 [/SUP], Zeid Neishwat[SUP] 2 [/SUP], Mamtha Balla[SUP] 3 [/SUP], Mitra Patel[SUP] 4 [/SUP], Rawish Fatima[SUP] 4 [/SUP], Taha Shiek[SUP] 2 [/SUP], Vinay Kotturi[SUP] 5 [/SUP], Venugopala Bommana[SUP] 6 [/SUP], Goutham Pulagam[SUP] 7 [/SUP], Brian Kaminski[SUP] 8 [/SUP]



Affiliations

Abstract

Introduction: The Coronavirus disease 2019 (COVID-19) pandemic continues to cause significant morbidity and mortality worldwide. This study aims to identify specific lab markers, complications, and treatments that may be associated with increased mortality in COVID-19 patients.
Methods: This study is retrospective in nature; it included 217 COVID-19 positive patients who were admitted to a ProMedica Health System hospital in Northwest Ohio, United States, between March 25 - June 16, 2020. We collected various laboratory values, complications, and treatment courses. T-test and Chi-squared analyses were used to predict mortality. COVID-19 test was confirmed via PCR.
Results: Of 217 patients included in the study, the mean age of the population was 63.13 (SD 17.8), of which 194 (89.4%, mean age 61.7 years) survived while 23 (10.6%, mean age 74.6 years) died. Among them, 53% were females and 47% male. Laboratory values that were associated with mortality were low hemoglobin (p-value 0.0046), elevated INR (p-value 0.0005), low platelets (p-value 0.0246) and elevated procalcitonin (p-value 0.0472). Marginally significant laboratory values included elevated troponin (p-value 0.0661), and elevated creatinine (p-value 0.0741). Treatment with either antibiotic, antifungals, antivirals, blood transfusion, steroids, and intubation were all statistically significant for mortality. COVID-19 related complications with either ARDS, myocarditis, elevated INR, septic shock, or age greater than 63 were significant predictors of mortality.
Conclusion: Low hemoglobin, elevated INR, Low platelet, elevated procalcitonin, treated with either antibiotic, antifungal, antiviral, blood transfusion, steroids, and intubation are associated with high mortality related to COVID-19 infection. Healthcare professionals must be aware of these predictors This article is protected by copyright. All rights reserved.

Keywords: 2019 nCoV; SARS CoV-2; complications; coronavirus; laboratory tests; mortality; pandemic; treatment.
 
Back
Top Bottom